IIA Funds Further Israeli R&D Into Crustacean Gene Modification

The Israel Innovation Authority (IIA) has approved additional funding for a joint research and development project focused on CRISPR gene-editing technology for crustaceans. This initiative aims to enhance important traits such as growth rate, disease resistance, and environmental adaptation.

The collaboration involves sustainable aquaculture firm Watershed AC, computational biotech company Evogene, and Ben-Gurion University, marking a continued investment in biotechnological advancements within Israel's aquaculture sector.